Ardelyx Management
Management criteria checks 3/4
Ardelyx's CEO is Mike Raab, appointed in Mar 2009, has a tenure of 15.75 years. total yearly compensation is $4.12M, comprised of 17% salary and 83% bonuses, including company stock and options. directly owns 0.5% of the company’s shares, worth $5.66M. The average tenure of the management team and the board of directors is 4.3 years and 9.2 years respectively.
Key information
Mike Raab
Chief executive officer
US$4.1m
Total compensation
CEO salary percentage | 17.0% |
CEO tenure | 15.8yrs |
CEO ownership | 0.5% |
Management average tenure | 4.3yrs |
Board average tenure | 9.2yrs |
Recent management updates
Recent updates
Ardelyx: A Small Bet Its Latest Setback Will Be Temporary
Dec 20Ardelyx Lost The Lawsuit, But The Kidney PATIENT Act Will Save It
Nov 24Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability
Nov 14Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Nov 03Ardelyx, Inc.'s (NASDAQ:ARDX) Shares Lagging The Industry But So Is The Business
Oct 24Is Ardelyx (NASDAQ:ARDX) Weighed On By Its Debt Load?
Aug 25Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 07Ardelyx Faces Rising Challenges Despite Revenue Growth
Aug 05Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 04Ardelyx: Increased Focus On Ibsrela Due To Xphozah's Uncertain Outlook
Jul 13Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge
Jul 05Ardelyx: Strong Execution, Fairly Valued
May 10Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
May 04Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade)
May 03Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing
Apr 17Ardelyx Shrugs Off 'Mixed' Q4 Earnings
Mar 13Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Feb 24Ardelyx Q4 Preview: Recent Bull Run May Pause While Market Digests 2024 Guidance
Feb 20Ardelyx's XPHOZAH Still An Afterthought To The Pros
Jan 31Ardelyx: FDA Approval For Xphozah Grants Further Sales Enhancement
Jan 10Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price
Jan 04Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt
Dec 14Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 03Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt
Jul 31Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now
Apr 17Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Mar 30Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Dec 14CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$73m |
Jun 30 2024 | n/a | n/a | -US$65m |
Mar 31 2024 | n/a | n/a | -US$66m |
Dec 31 2023 | US$4m | US$700k | -US$66m |
Sep 30 2023 | n/a | n/a | -US$27m |
Jun 30 2023 | n/a | n/a | -US$56m |
Mar 31 2023 | n/a | n/a | -US$66m |
Dec 31 2022 | US$2m | US$650k | -US$67m |
Sep 30 2022 | n/a | n/a | -US$114m |
Jun 30 2022 | n/a | n/a | -US$135m |
Mar 31 2022 | n/a | n/a | -US$153m |
Dec 31 2021 | US$4m | US$650k | -US$158m |
Sep 30 2021 | n/a | n/a | -US$151m |
Jun 30 2021 | n/a | n/a | -US$125m |
Mar 31 2021 | n/a | n/a | -US$105m |
Dec 31 2020 | US$4m | US$633k | -US$94m |
Sep 30 2020 | n/a | n/a | -US$85m |
Jun 30 2020 | n/a | n/a | -US$91m |
Mar 31 2020 | n/a | n/a | -US$91m |
Dec 31 2019 | US$2m | US$595k | -US$95m |
Sep 30 2019 | n/a | n/a | -US$103m |
Jun 30 2019 | n/a | n/a | -US$104m |
Mar 31 2019 | n/a | n/a | -US$100m |
Dec 31 2018 | US$4m | US$575k | -US$91m |
Sep 30 2018 | n/a | n/a | -US$53m |
Jun 30 2018 | n/a | n/a | -US$50m |
Mar 31 2018 | n/a | n/a | -US$53m |
Dec 31 2017 | US$5m | US$555k | -US$64m |
Compensation vs Market: Mike's total compensation ($USD4.12M) is about average for companies of similar size in the US market ($USD3.22M).
Compensation vs Earnings: Mike's compensation has increased whilst the company is unprofitable.
CEO
Mike Raab (59 yo)
15.8yrs
Tenure
US$4,118,144
Compensation
Mr. Michael G. Raab, also known as Mike, has been the Chief Executive Officer and President of Ardelyx, Inc. since March 2009. He is a Director of Tempest Therapeutics Inc. since May 2019 and its Chairman...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 15.8yrs | US$4.12m | 0.50% $ 5.7m | |
Chief Legal & Administrative Officer and Secretary | 10.6yrs | US$1.63m | 0.078% $ 891.5k | |
Chief Medical Officer | 4.1yrs | US$1.63m | 0.13% $ 1.5m | |
Chief Financial & Operations Officer | 4.5yrs | US$1.73m | 0.12% $ 1.4m | |
Senior VP of Finance & Principal Accounting Officer | less than a year | no data | no data | |
Vice President of Corporate Communications & Investor Relations | no data | no data | no data | |
Executive Vice President of Corporate Development & Strategy | less than a year | no data | no data | |
Chief Human Resources Officer | 1.9yrs | no data | no data | |
Chief Development Officer | 9.9yrs | US$1.63m | 0.22% $ 2.5m | |
Chief Regulatory Affairs & Quality Assurance Officer | no data | US$1.70m | 0.13% $ 1.5m | |
Advisor | 4.6yrs | US$1.04m | 0.19% $ 2.2m | |
Chief Commercial Officer | less than a year | no data | no data |
4.3yrs
Average Tenure
60yo
Average Age
Experienced Management: ARDX's management team is considered experienced (4.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 15.8yrs | US$4.12m | 0.50% $ 5.7m | |
Independent Chairman of the Board | 15.8yrs | US$249.90k | 0.69% $ 7.9m | |
Independent Director | 9.2yrs | US$214.90k | 0.097% $ 1.1m | |
Independent Director | 10.8yrs | US$222.40k | 0.11% $ 1.2m | |
Independent Director | 8.5yrs | US$202.40k | no data | |
Independent Director | 4.8yrs | US$199.90k | 0.047% $ 529.9k | |
Independent Director | 3.8yrs | US$202.40k | 0.040% $ 460.8k |
9.2yrs
Average Tenure
59yo
Average Age
Experienced Board: ARDX's board of directors are considered experienced (9.2 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/27 23:29 |
End of Day Share Price | 2024/12/27 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ardelyx, Inc. is covered by 17 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Timothy Chiang | BTIG |
Mara Goldstein | Cantor Fitzgerald & Co. |
Louise Chen | Cantor Fitzgerald & Co. |